Generic Price Fixing Probe: First Charges Unsealed, More May Come Before Inauguration Day
Heritage Pharmaceuticals’ former CEO and former president charged by US DOJ with conspiracy to fix prices and allocate customers for doxycycline and glyburide; Heritage alleges they embezzled intellectual property.
You may also be interested in...
Teva Agrees To $420m Securities Settlement For Alleged Price Fixing
Denying any wrongdoing or admission of liability, Teva has agreed to a proposed settlement of $420m with a class of investors following allegations that the firm had concealed the true nature of its increase in profits, which artificially inflated the price of Teva’s securities.
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Off-label marketing and kickbacks may no longer be the top targets of government healthcare fraud investigations as more companies are being hit with subpoenas for pricing information.
Generic Drug Pricing Probe: Allergan Latest Firm Hit With DOJ Subpoena
US Department of Justice is investigating at least four firms; Sen. Bernie Sanders questioned Allergan about price hike for its antibiotic doxycycline.